Yiyeon Pharmaceutical pursues asset securitization of Chungju plant... "Secure ₩100B, will create business synergy"
Predicted impact: Medium
Plant securitization targeting ₩100B, about 54% of market value, though it is financing, not equity.
Comments
No comments yet. Start the conversation.
Comments are people's own views. Nothing here is financial advice.